Question 1

Who is Catriona Yale?

Accepted Answer

Catriona Yale serves as Executive at Akero Therapeutics, Inc. (AKRO). They have executed 66 insider transactions totaling $7.4M over their tenure at the company.

Question 2

What is Catriona Yale's role at Akero Therapeutics, Inc.?

Accepted Answer

Catriona Yale holds the position of Executive at Akero Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.

Question 3

Is Catriona Yale buying or selling AKRO stock?

Accepted Answer

Catriona Yale has shown a selling trading pattern, with $0 in total purchases and $7.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.

Question 4

What are Catriona Yale's largest insider transactions?

Accepted Answer

The largest transaction by Catriona Yale was on Mar 4, 2024, when they sold $732.7K worth of AKRO shares. This transaction involved 20,646 shares at $35.49 per share.

Question 5

What is Catriona Yale's trading accuracy?

Accepted Answer

Catriona Yale has a Personal Accuracy Score of 94/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Catriona Yale associated with?

Accepted Answer

Catriona Yale has filed Form 4 transactions for 1 different company. Their primary association is with Akero Therapeutics, Inc. (AKRO), where they serve as Executive.

Question 7

How much AKRO stock does Catriona Yale own?

Accepted Answer

Catriona Yale currently owns 74,800 shares of Akero Therapeutics, Inc. (AKRO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Catriona Yale's equity in Akero Therapeutics, Inc.?

Accepted Answer

Catriona Yale's equity position in Akero Therapeutics, Inc. consists of 74,800 shares valued at approximately $0. As Executive, they have executed 66 insider transactions, with $0 in purchases and $7.4M in sales.

Question 9

Where can I find Catriona Yale's SEC Form 4 filings?

Accepted Answer

All of Catriona Yale's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Catriona Yale has 66 Form 4 filings on record as an insider at Akero Therapeutics, Inc..

Question 10

What is Catriona Yale's net worth from AKRO?

Accepted Answer

Based on their current AKRO stock holdings, Catriona Yale has equity worth approximately $0 in Akero Therapeutics, Inc.. This value is based on 74,800 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Dec 9, 2025	AKRO	$0	Disposition	47,573	$N/A	Discretionary
Dec 9, 2025	AKRO	$0	Disposition	27,227

Catriona Yale

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Catriona Yale Trading Summary

How Much AKRO Stock Does Catriona Yale Own?

Is Catriona Yale Buying or Selling AKRO?

Catriona Yale's Recent Stock Transactions

Frequently Asked Questions

Track Catriona Yale's Trades